A triple combination of anti-PD-1, albumin/AlbiVax nanocomplexes, and chemotherapeutic Abraxane that enhances tumor immunity50,51, further inhibited the tumor progression (Fig. 5f). The gene discussed is ALB; the disease is neoplasm.